Bill Status of HB 332   96th General Assembly

Short Description:  PRESCRIPTION DRUG ETHICAL ACT

House Sponsors
Rep. Jack D. Franks, Fred Crespo, Deborah Mell and Eddie Washington

Last Action  View All Actions

DateChamber Action
  1/11/2011HouseSession Sine Die

Statutes Amended In Order of Appearance
New Act
30 ILCS 105/5.719 new

Synopsis As Introduced
Creates the Prescription Drug Ethical Marketing Act. Requires every manufacturer and labeler that sells prescription drugs in the State to disclose to the Director of Public Health the value, nature, and purpose of any gift, fee, payment, subsidy, or other economic benefit provided in connection with detailing or promotional or other marketing activities by the company, directly or through its pharmaceutical marketers, to any physician, hospital, nursing home, pharmacist, health benefit plan administrator, or any other person in the State authorized to prescribe or dispense prescription drugs. Requires the Director to report to the Governor and the General Assembly on the disclosures. Provides exceptions to the disclosures. Provides for injunctive relief and civil penalties for failure to disclose. Amends the State Finance Act to create the Prescription Drug Ethical Marketing Fund.

Actions 
DateChamber Action
  1/23/2009HouseFiled with the Clerk by Rep. Jack D. Franks
  1/27/2009HouseFirst Reading
  1/27/2009HouseReferred to Rules Committee
  2/4/2009HouseAssigned to Human Services Committee
  2/6/2009HouseAdded Co-Sponsor Rep. Fred Crespo
  3/13/2009HouseRule 19(a) / Re-referred to Rules Committee
  1/27/2010HouseAssigned to Human Services Committee
  2/19/2010HouseAdded Co-Sponsor Rep. Deborah Mell
  3/15/2010HouseRule 19(a) / Re-referred to Rules Committee
  3/26/2010HouseAdded Co-Sponsor Rep. Eddie Washington
  1/11/2011HouseSession Sine Die

Back To Top